Having revealed the overexpression of SUZ12 and its clinical significance in HNSCC, we next sought to dissect its oncogenic roles driving HNSCC initiation and progression by shRNA‐mediated loss‐of‐function approach. Here, SUZ12 is linked to head and neck squamous cell carcinoma.